JC

Jon Congleton

Chief Executive Officer

Mineralys Therapeutics, Inc.

Malvern, Pennsylvania


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Mineralys Therapeutics, Inc.
Industry
research
Employees
67.0
Seniority
C suite
Annual Revenue
1000000.0

Technologies

Cloudflare DNS Outlook Google Cloud Hosting WP Engine Greenhouse.io WordPress.org Nginx Google Font API reCAPTCHA Google Tag Manager Apache Mobile Friendly Data Analytics Render IoT Remote AI

Keywords

biotechnology: pharmaceutical preparations health care biotechnology research hypertension aldosterone lorundrostat aldosterone synthase inhibitor cardio-renal-metabolic syndrome ckd treatment-resistant hypertension clinical trials patients with hypertension obesity-related hypertension blood pressure control patient-centric focus targeted treatment chronic kidney disease adverse effect management sodium-glucose cotransporter first aldosterone inhibitor phase 2 trials clinical development biopharmaceuticals innovative therapies pharmaceutical partnerships drug efficacy safety & tolerability biomarker discovery investigational drugs uncontrolled hypertension renal health hypertension management medical advancements patient outcomes treatment targets healthcare collaboration medical affairs evidence-based practice patient compliance regulatory affairs therapeutic areas risk reduction strategies drug development research partnerships clinical pharmacology pharmacovigilance healthcare professionals wellness benefits employee engagement health education diverse team life sciences remote work culture health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans